Advertisement

Laparoscopic Splenectomy for Malignant Diseases

  • R. Matthew Walsh
  • B. Todd Heniford
Chapter

Abstract

Since Delaitre and Maignien [1] reported the first laparoscopic splenectomy in 1991, the utility of laparoscopic splenectomy in the treatment of hematologic diseases such as hereditary spherocytosis, immune thrombocytopenic purpura, and autoimmune hemolytic anemia has been well established. Thousands of cases in the surgical literature have documented laparoscopic splenectomy as safe and effective in the management of these benign hematologic disorders. As with other minimally invasive surgical techniques, when compared to conservative or open surgery, patients appear to benefit from rapid advancement of diet, reduced postoperative pain and analgesic requirements, a shorter postoperative hospital stay, and an improved cosmetic result. Additionally, the period of convalescence is brief with an early return to work and normal activities.

Keywords

Immune Thrombocytopenic Purpura Laparoscopic Splenectomy Hairy Cell Leukemia Operative Blood Loss Hereditary Spherocytosis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Delaitre B, Maignien B (1991) Splenectomy by the laparoscopic approach. Report of a case. Presse Med 20:2263PubMedGoogle Scholar
  2. 2.
    Huber MR, Kumar S, Tefferi A (2003) Treatment advances in adult immune thrombocytopenic purpura. Ann Hematol 82:723–737PubMedCrossRefGoogle Scholar
  3. 3.
    Rescorla FJ (2002) Laparoscopic splenectomy. Semin Pediatr Surg 11:226–232PubMedCrossRefGoogle Scholar
  4. 4.
    Park A, Targarona EM, Trias M (2001) Laparoscopic surgery of the spleen: state of the art. Langenbecks Arch Surg 386:230–239PubMedCrossRefGoogle Scholar
  5. 5.
    Brunt LM, Langer JC, Quasebarth MA et al (1996) Comparative analysis of laparoscopic vs. open splenectomy. Am J Surg 173:596–601CrossRefGoogle Scholar
  6. 6.
    Smith CD, Meyer TA, Goretsky MJ et al (1996) Laparoscopic splenectomy by the lateral approach: a safe and effective alternative to open splenectomy for hematologic diseases. Surgery 120:789–794PubMedCrossRefGoogle Scholar
  7. 7.
    Walsh RM, Heniford BT, Brody F, Ponsky J (2001) The ascendance of laparoscopic splenectomy. Am Surg 67:48–53PubMedGoogle Scholar
  8. 8.
    Janu PG, Rogers DA, Lobe TE (1996) A comparison of laparoscopic and traditional open splenectomy in childhood. J Pediatr Surg 31:109–114PubMedCrossRefGoogle Scholar
  9. 9.
    Friedman RL, Fallas MJ, Carroll BJ et al (1996) Laparoscopic splenectomy for ITP: the gold standard. Surg Endosc 10:991–995PubMedCrossRefGoogle Scholar
  10. 10.
    Gigot JF, Lengele B, Gianello P et al (1998) Present status of laparoscopic splenectomy for hematologic diseases: certitudes and unresolved issues. Semin Laparosc Surg 5:147–167PubMedGoogle Scholar
  11. 11.
    Mittelman A, Stutzman L, Grace JT (1968) Splenectomy in malignant lymphoma and leukemia. Geriatrics 23:142–149PubMedGoogle Scholar
  12. 12.
    Walsh RM, Brody F, Brown N (2004) Laparoscopic splenectomy for lymphoproliferative disease. Surg Endosc 18:272–275PubMedCrossRefGoogle Scholar
  13. 13.
    Giulliani A, Caporale A, DiBari M et al (1999) Isolated splenic metastasis from endometrial carcinoma. J Exp Clin Cancer Res 18:93–99Google Scholar
  14. 14.
    Kyzer S, Koren R, Klein B et al (1998) Giant splenomegaly caused by splenic metastases of melanoma. Eur J Surg 24:336–337Google Scholar
  15. 15.
    Colovic MD, Jankovic GM, Golovic RB et al (1998) Non-secretory solitary plasmacytoma of the spleen. Med Oncol 15:286–288PubMedCrossRefGoogle Scholar
  16. 16.
    Mallipudi BV, Chawdhery MZ, Jeffery PJ (1998) Primary malignant fibrous histiocytoma of spleen. Eur J Surg Oncol 24:448–449PubMedCrossRefGoogle Scholar
  17. 17.
    Tubiana M (1991) Hodgkin’s disease: historical perspective and clinical presentation. In: Bailliere’s clinical hematology, vol 9. Balliere Tindall, Philadelphia, pp 503–530Google Scholar
  18. 18.
    Hodgson DC (2008) Hodgkin lymphoma: the follow-up of long-term survivors. Hematol Oncol Clin North Am 22(2):233–244PubMedCrossRefGoogle Scholar
  19. 19.
    Mauch PM (1996) Management of early stage Hodgkin’s disease. In: Bailliere’s clinical hematology, vol 9. Balliere Tindall, Philadelphia, 531–541Google Scholar
  20. 20.
    Klimm B, Engert A, Diehl V (2005) First-line treatment of Hodgkin’s lymphoma. Curr Hematol Rep 4:15–22PubMedGoogle Scholar
  21. 21.
    Lister TA, Crowther D, Sutcliffe SB et al (1989) Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin’s disease. J Clin Oncol 7:1630–1636PubMedGoogle Scholar
  22. 22.
    Sprecht L, Lauritzen AF, Nordentoft AM et al (1990) Tumor cell concentration and tumor cell burden in relation to histopathologic subtype and other prognostic factors in early stage Hodgkin’s disease. The Danish National Hodgkin’s Study Group. Cancer 65:2594–2601CrossRefGoogle Scholar
  23. 23.
    Kasamon YL, Wahl RL (2008) FDG PET and risk-adapted therapy in Hodgkin’s and non-Hodgkin’s lymphoma. Curr Opin Oncol 20:206–219PubMedCrossRefGoogle Scholar
  24. 24.
    Bartlett NL (2008) Modern treatment of Hodgkin lymphoma. Curr Opin Hematol 14:408–414CrossRefGoogle Scholar
  25. 25.
    Leibenhaut M (1989) Prognostic indicators of laparotomy findings in clinical stage I-II supradiaphragmatic Hodgkin’s disease. J Clin Oncol 7:81–91PubMedGoogle Scholar
  26. 26.
    Mauch P, Larson D, Osteen R et al (1990) Prognostic factors for positive staging in patients with Hodkin’s disease. J Clin Oncol 8:257–265PubMedGoogle Scholar
  27. 27.
    Jockovick M, Mendenhall NP, Sombeck MD et al (1994) Long-term complications of laparotomy in Hodgkin’s disease. Ann Surg 219:615–624CrossRefGoogle Scholar
  28. 28.
    Lehne G, Hannisdal E, Langholm R, Nome OA (1994) 10-year experience with splenectomy in patients with malignant non-Hodgkin’s lymphoma. Cancer 74:933–939PubMedCrossRefGoogle Scholar
  29. 29.
    Delpero JR (1990) Splenectomy for hypersplenism in chronic lymphocytic leukemia and malignant non-Hodgkin’s lymphoma. Br J Surg 77:443–449PubMedCrossRefGoogle Scholar
  30. 30.
    Brodsky J, Abcar A, Styler M (1996) Splenectomy for non-Hodgkin’s lymphoma. Am J Clin Oncol 19:558–561PubMedCrossRefGoogle Scholar
  31. 31.
    Konradsen HB (1996) Humoral immune response to pneumococcal vaccination: prevention of infections with Streptococcus pneumonia by immunization. APMIS 60:1–28Google Scholar
  32. 32.
    Brox A, Bishinski JI, Berry G (1991) Primary non-Hodgkin’s lymphoma of the spleen. Am J Hematol 38:95–100PubMedCrossRefGoogle Scholar
  33. 33.
    Xiros N, Economopoulos T, Christodoulidis C et al (2000) Splenectomy in patients with malignant non-Hodgin’s lymphoma. Eur J Haematol 64:145–150PubMedCrossRefGoogle Scholar
  34. 34.
    Kercher KW, Matthews BD, Walsh RM et al (2002) Laparoscopic splenectomy for massive splenomegaly. Am J Surg 183:192–196PubMedCrossRefGoogle Scholar
  35. 35.
    Saven A, Piro LD (1992) Treatment of hairy cell leukemia. Blood 79:111–1120Google Scholar
  36. 36.
    Jansen J, Hermans J (1981) Splenectomy in hairy cell leukemia: a retrospective multice analysis. Cancer 47:2066–2076PubMedCrossRefGoogle Scholar
  37. 37.
    Ulrich M, Strehl J, Gorschluter M et al (2003) Advances in the treatment of hairy-cell leukemia. Lancet Oncol 4:86–94CrossRefGoogle Scholar
  38. 38.
    Burch M, Misra M, Phillips EH (2005) Splenic malignancy: a minimally invasive approach. Cancer J 11:36–42PubMedCrossRefGoogle Scholar
  39. 39.
    Baccarani M (1984) Results of a prospective randomized trial of early splenectomy in chronic myeloid leukemia. The Italian Coopertive Study Group on chronic myeloid leukemia. Cancer 54:333–338CrossRefGoogle Scholar
  40. 40.
    Feldman LS, Demyttenaere SV, Polyhronopoulos GN et al (2008) Refining the selection criteria for laparoscopic \ open splenectomy for splenomegaly. J Laparoendosc Adv Surg Tech A 1:13–19CrossRefGoogle Scholar
  41. 41.
    Nelson E, Mone M (1999) Splenectomy in high risk patients with splenomegaly. Am J Surg 178:581–586PubMedCrossRefGoogle Scholar
  42. 42.
    Heniford BT, Park A, Walsh RM et al (2001) Laparoscopic splenectomy in patients with normal-sized spleens versus splenomegaly: does size matter? Am Surg 67:865–867, discussion 857–858Google Scholar
  43. 43.
    Owera A, Hamade Am, Ol B, Ammori BJ (2006) Laparoscopic versus open splenectomy for massive splenomegaly: a comparative study. J Laparoendosc Adv Surg Tech A 16:241–246PubMedCrossRefGoogle Scholar
  44. 44.
    Grahn SW, Alvarez J, Kirkwood K (2006) Trends in laparoscopic splenecomy for massive splenomegaly. Arch Surg 141:755–762PubMedCrossRefGoogle Scholar
  45. 45.
    Dominguez EP, Choi EP, Scott YU et al (2007) Impact of morbid obesity on outcome of laparoscopic splenectomy. Surg Endosc 21:422–426PubMedCrossRefGoogle Scholar
  46. 46.
    Berindoague R, Targarona EM, Balague C et al (2007) Can we predict immediate outcome after laparoscopic splenectomy for splenomegaly? Multivariate analysis of clinical, anatomic, and pathologic features after 3D reconstruction of the spleen. Surg Innov 14:243–251PubMedCrossRefGoogle Scholar
  47. 47.
    Cobb WS, Heniford BT, Burns JM et al (2005) Cirrhosis is not a contraindication to laparoscopic surgery. Surg Endosc 19:418–423PubMedCrossRefGoogle Scholar
  48. 48.
    Kercher KW, Carbonell AM, Heniford BT et al (2004) Laparoscopic splenectomy reverses thrombocyto[penia] in patients with hepatitis C cirrhosis and portal hypertension. J Gast Surg 8:120–126CrossRefGoogle Scholar
  49. 49.
    Walsh RM, Chand B, Brodsky J, Heniford BT (2003) Determination of intact splenic weight based on morcellated weight. Surg Endosc 17:1266–1268PubMedCrossRefGoogle Scholar
  50. 50.
    Nicholson IA, Falk GI, Muligan SC (1998) Laparoscopically assisted massive splenectomy: a preliminary report of the technique of early hilar devascularization. Surg Endosc 12:73–75PubMedCrossRefGoogle Scholar
  51. 51.
    Price VE, Dutta S, Blanchette VS et al (2006) The prevention and treatment of bacterial infections in children with asplenia or hyposplenia: practice considerations at the hospital for sick children, Toronto. Pediatr Blood Cancer 46:597–603PubMedCrossRefGoogle Scholar
  52. 52.
    Winther TN, Kristensen TD, Kaltoft MS, Konradsen HB, Knudsen JD, Hogh B (2009) Invasive pneumococcal disease in Danish children, 1996-2007, prior to the introduction of heptavalent pneumococcal conjugate vaccine. Acta Paediatr 98:328–331PubMedCrossRefGoogle Scholar
  53. 53.
    Poulin EC, Thibault C (1993) The anatomical basis for laparoscopic splenectomy. Can J Surg 36:484–488PubMedGoogle Scholar
  54. 54.
    Park A, Gagner M, Pomp A (1997) The lateral approach to laparoscopic splenectomy. Am J Surg 173:126–130PubMedCrossRefGoogle Scholar
  55. 55.
    Dawson AA, Jones PF, King DJ (1987) Splenectomy in the management of hematological disease. Br J Surg 74:353–357PubMedCrossRefGoogle Scholar
  56. 56.
    Horowitz J, Smith JL, Weber TK et al (1996) Post-operative complications after splenectomy for hematologic malignancies. Ann Surg 223:290–296PubMedCrossRefGoogle Scholar
  57. 57.
    Friedman RL, Hiatt JR, Korman JL et al (1997) Laparoscopic or open splenectomy for hematologic disease: which approach is superior? J Am Coll Surg 185:49–54PubMedGoogle Scholar
  58. 58.
    Rosen M, Brody F, Walsh RM et al (2002) Outcome of laparoscopic splenectomy based on hematologic indication. Surg Endosc 16:272–279PubMedCrossRefGoogle Scholar
  59. 59.
    Balague C, Targarona EM, Cerdan G et al (2004) Long-term outcome after laparoscopic splenectomy related to hematologic diagnosis. Surg Endosc 18:1283–1287PubMedCrossRefGoogle Scholar
  60. 60.
    Chand B, Walsh RM, Ponsky J, Brody F (2001) Pancreatic complications following laparoscopic splenectomy. Surg Endosc 15:1273–1276PubMedCrossRefGoogle Scholar
  61. 61.
    Berman RS, Yahanda AM, Mansfield PF et al (1999) Laparoscopic splenectomy in patients with hematologic malignancies. Am J Surg 178:530–536PubMedCrossRefGoogle Scholar
  62. 62.
    Rosen M, Brody F, Walsh RM, Ponsky J (2002) Hand-assisted laparoscopic splenectomy vs. conventional laparoscopic splenectomy in cases of splenomegaly. Arch Surg 137:1348–1352PubMedCrossRefGoogle Scholar
  63. 63.
    Wang K, Hu S, Zhang G et al (2007) Hand-assisted laparoscopic splenectomy for splenomegaly: a comparative study with conventional laparoscopic splenectomy. Chin Med J 120:41–45PubMedGoogle Scholar
  64. 64.
    Walsh RM, Heniford BT (1999) Role of laparoscopy for Hodgkin’s and non-Hodgkin’s lymphoma. Semin Surg Oncol 16:284–292PubMedCrossRefGoogle Scholar
  65. 65.
    Targarona EM, Balague C, Trias M (2007) Is the laparoscopic approach reasonable in cases of splenomegaly? Sem Laparosc Surg 11:185–190Google Scholar
  66. 66.
    Park A, Targarona EM, Trias M (2001) Laparoscopic surgery of the spleen: state of the art. Langenbecks Arch Surg 386:230–239PubMedCrossRefGoogle Scholar
  67. 67.
    Torelli P, Cavaliere D, Casaccia M, Panaro F, Grondona P, Rossi E, Santini G, Truini M, Gobbi M, Bacigalupo A, Valente U (2002) Laparoscopic splenectomy for hematological diseases. Surg Endosc 16:965–971PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2009

Authors and Affiliations

  • R. Matthew Walsh
    • 1
    • 2
  • B. Todd Heniford
    • 3
  1. 1.Lerner College of MedicineCase Western UniversityClevelandUSA
  2. 2.Department of General SurgeryCleveland ClinicClevelandUSA
  3. 3.Division of GI and Minimal Access SurgeryCarolinas Medical CenterCharlotteUSA

Personalised recommendations